
Medical and Pharmacy Editor: Jay W. Marks, MD
GENERIC NAME: fluticasone propionate and salmeterol
oral inhaler
BRAND NAME: Advair Diskus
DRUG CLASS AND MECHANISM: Advair Diskus is a combination of inhaled
drugs that is used to treat asthma and chronic bronchitis. In
patients with asthma, the airways (bronchioles) through which air moves in and out of the
lungs can be narrowed by accumulation of mucus, spasm of the muscles that
surround these airways, or swelling of the lining of the airways due to
inflammation. Airway narrowing leads to symptoms of shortness of breath,
wheezing, cough and congestion. Medications used in treating asthma include
those that open airways, called bronchodilators, and those that reduce
inflammation.
Advair Diskus contains a combination of salmeterol, a bronchodilator of the
beta-2 agonist type, and fluticasone propionate, an anti-inflammatory
corticosteroid. Beta-2 agonists are medications that attach to beta-2 receptors
on the smooth muscle cells that surround the airways, causing the muscle cells
to relax and open the airways. Fluticasone propionate is a synthetic (man-made)
corticosteroid of the glucocorticoid family which is related to the natural
hormone, cortisol or hydrocortisone, produced by the adrenal glands.
Glucocorticoid steroids have potent anti-inflammatory actions. In asthmatic
patients, the suppression of inflammation within the airways reduces the
swelling caused by inflammation that narrows the airways. At the same time,
mucus is reduced. When used in lower doses, very little inhaled fluticasone
propionate is absorbed into the body. When higher doses are used, fluticasone is
absorbed and may cause side effects elsewhere in the body.
PRESCRIPTION: Yes
GENERIC AVAILABLE: No
PREPARATIONS: Advair Diskus is available in three different forms
containing the same amount of salmeterol, 50 mcg, but differing in the amount of
fluticasone propionate. 100/50 provides 100 mcg of fluticasone propionate,
250/50 provides 250 mcg of fluticasone propionate, and 500/50 contains 500 mcg
of fluticasone propionate per inspiration.
STORAGE: Advair Diskus should be stored at 36-86 ° F. It should be
kept away from heat or flames and should not be punctured; it should not be
frozen or placed in direct sunlight.
PRESCRIBED FOR: Advair
Diskus is used for the treatment of asthma or
chronic obstructive pulmonary disease (COPD) associated with chronic bronchitis.
Its action starts within 30 to 60 minutes and can last more than 12 hours.
Advair Diskus is generally not needed in patients whose asthma can be controlled
easily with infrequent administration of short acting inhalers. Advair Diskus
should not be used to treat acute episodes of asthma or COPD.
DOSING: The recommended regimen for asthma in individuals 12 years and
older is one inhalation twice daily (morning and evening) approximately 12 hours
apart. The lowest effective strength should be used and the maximum dose is
500/50 mcg twice daily. For children 4 to 11 years old the recommended treatment
is one inhalation of 100/50 mcg twice daily.
The recommended regimen for COPD is one inhalation of 250/50 mcg twice daily.
Higher doses are not more effective.
The Diskus device is held in one hand with the thumb of the other hand placed
on the thumb-grip. The thumb is then pulled away as far as the device allows
until the mouthpiece seems to click into position. With the Diskus then held
horizontally and with the mouthpiece towards the patient, the lever is then slid
away as far as it can go until it clicks. The patient breathes out as far as
comfortable, then placing his mouth to the mouthpiece, breathes in quickly and
deeply and holds his breath for about ten seconds. The patient then washes his
or her mouth without swallowing after inhalation.
DRUG INTERACTIONS: Monoamine oxidase inhibitors (e.g.,
tranylcypromine) and tricyclic antidepressants (e.g., amitriptyline) may
increase the effect of salmeterol on the heart and blood pressure. Since Advair
Diskus contains salmeterol, it should not be used with or within 2 weeks of
discontinuing monoamine oxidase inhibitors or tricyclic antidepressants.
PREGNANCY: Adequate studies
of fluticasone or inhaled salmeterol during pregnancy
have not been done. Fluticasone use during pregnancy should be
avoided unless the potential benefit justifies the potential but unknown risk to
the fetus. In some, but not all, pregnant animal models exposure to very high
doses of oral salmeterol has led to offspring with birth defects. The
concentrations of salmeterol in the blood after these very high doses, however,
were much higher than the concentrations observed after inhalation. Salmeterol
inhalation should be used during pregnancy only if the potential benefit
justifies the potential risk to the fetus.
NURSING MOTHERS: It is not known if fluticasone propionate is secreted
in breast milk. Other medications in the same class as fluticasone propionate
are secreted into breast milk, but it is not known whether the small amounts
that may appear in the milk have effects on nursing infants. In rats, salmeterol
is excreted in milk. Therefore, caution should be exercised when salmeterol is
administered to nursing women.
SIDE EFFECTS: Upper respiratory tract infections occur in 20-25% of
patients using Advair Diskus. Headaches occur in about 1 in 8 patients who use
it. Other potential adverse events include nausea, vomiting, diarrhea, mouth or
throat candidiasis, and musculoskeletal pain. Use of long acting agents like
salmeterol, an active ingredient in Advair Diskus, may increase the risk of
asthma-related death. Therefore Advair Diskus should only be used in patients
uncontrolled by other agents.
Last Editorial Review: 7/27/2006
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
 |
 |
From the Doctors at MedicineNet.com  |
 |
 |
- Asthma - Get the facts on asthma symptoms, signs, diagnosis, causes and triggers of asthma attacks, treatment information, medication, inhalers, and management. Asthma in children and exercise-induced asthma are types of asthma. Source:MedicineNet
- Emphysema - Learn about emphysema, a progressive lung disease. Emphysema is a symptom of COPD (chronic obstructive pulmonary disease) with symptoms like shortness of breath, wheezing. Manifestations of COPD include chronic bronchitis, asthma, bronchiectasis, and emphysema. Source:MedicineNet
- Asthma in Children - Read about asthma in kids (children). Learn about asthma statistics, diagnosis, symptoms, signs, and medications. Find out what to do when your kid has an asthma attack. Source:WebMD Medical Reference from The Cleveland Clinic
- Read 30 more fluticasone and salmeterol oral inhaler related articles ...
|
| |
 |
Back to Medications Index